News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
finance.yahoo.com Market update
Argenx stock surged Monday after its blockbuster autoimmune drug, Vyvgart, showed promise in patients with inflammatory diseases. Continue Reading
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
argenx SE Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; consistent treatment effect across IMNM and DM First Phase 3 …
Sharemaestro market context Trend signal active 52 weeks +23.7% · Next-week setup negative 39.6%This article lists several ETFs that invest in Iperionx Ltd. Sponsored ADR stocks, providing details such as market value, weight, issuer, management style, expense ratio, and AUM for each fund. The funds aim to make investing in stocks more accessible and offer diversified opportunities …
NXP Semiconductors is experiencing a significant demand rebound across its markets, with book-to-bill ratios exceeding one and normalized distribution inventory. Key growth drivers include automotive technology, particularly software-defined vehicles and AI applications, and the data center business, which is projected to double this year. …
Walleye Capital LLC has invested $2.44 million in REGENXBIO Inc. by acquiring 203,726 shares during the second quarter, making them one of many institutional investors in the company. REGENXBIO exceeded analyst expectations with its recent earnings report, posting $0.43 EPS and $108.02 million in …
Walleye Capital LLC has made a new investment in Crane NXT, Co. (NYSE:CXT), purchasing 20,830 shares valued at approximately $1.07 million in the second quarter. This comes as Crane NXT exceeded quarterly earnings expectations, reporting $1.10 per share against a $1.04 consensus and revenue …
StablecoinX (USDE) reported a net loss of $34.6 million for the first half of 2026, primarily due to a $36.2 million impairment on its ENA digital intangible assets. Despite this loss, the company holds significant assets, including a $212.9 million ENA token treasury. The …
Crane NXT (CXT) reported strong Q2 sales of US$493.2 million and net income of US$35.4 million, reaffirming its 2026 sales growth guidance and maintaining its quarterly dividend. Despite a 35.20% gain over 90 days, the stock is down 12.17% over the last year, leading …
T. Rowe Price Associates, Inc. has disclosed a beneficial ownership of 2,675,457 argenx SE ADRs as of June 30, 2026, representing a 4.3% stake. The firm holds sole voting power over 2,649,465 ADRs and sole dispositive power over all 2,675,457 ADRs, explicitly denying beneficial …
Pulmonx Corporation (LUNG) has been identified as a strong momentum stock by Zacks Equity Research, boasting a Momentum Style Score of B and a Zacks Rank of #2 (Buy). The company has shown significant short-term and long-term price performance, outperforming both its industry and …
Argenx stock is consolidating after a strong Q2 2026 earnings beat and a significant $2.2 billion acquisition of Forte Biosciences. Despite a recent pullback, the stock remains in positive territory year-to-date, with analysts maintaining a constructive outlook and an implied upside of roughly 23% …
StableCoinX announced its Q2 2026 results, reporting $62,372 in revenue and total assets of $232.6 million, including $212.9 million in digital intangible assets. The company also disclosed an ENA treasury of approximately 3.0 billion tokens. These results follow its recent business combination with TLGY …
StablecoinX (Nasdaq: USDE) reported a net loss of $34.2 million for its second quarter ended June 30, 2026, primarily due to a $36.2 million impairment on digital intangible assets. Despite the loss, the company built a substantial ENA treasury of approximately 3.0 billion tokens, …
Zacks Research has upgraded REGENXBIO (NASDAQ:RGNX) from a "strong sell" to a "hold" rating. This upgrade comes as the biotechnology company exceeded revenue and EPS estimates in its latest quarterly report, though it remains unprofitable. Institutional investors hold a significant portion of the company's …
NewEdge Advisors LLC reduced its stake in CNX Resources Corporation (NYSE:CNX) by 30.3% in the first quarter, selling 30,997 shares and retaining 71,294 shares valued at $2.75 million. Despite this reduction, institutional ownership of CNX Resources remains high at 95.16%, with several other major …
Company Logo Sustained global demand for crop protection products and broader adoption of low-waste synthesis routes, highlighted by process optimizations and capacity positioning across Wynca Group, Hubei Xingfa Chemicals Group Co., Ltd., LANXESS AG, ICL Group, and Xuzhou Yongda Chemical Co., Ltd. are driving …
Key Points Interested in Talanx AG? Here are five stocks we like better. Record earnings and raised outlook: Talanx reported first-half 2026 net income of €1.499 billion, up 9% year over year, with a 21.5% return on equity. It now expects full-year net income …
Sharemaestro market context Trend signal active 52 weeks +1.6% · Next-week setup positive 58.9%Assenagon Asset Management S.A. significantly reduced its stake in REGENXBIO Inc. by 82.7% in the second quarter, now holding 169,279 shares valued at $2.03 million. Despite this, institutional investors still own a substantial 88.08% of the company. REGENXBIO recently surpassed analyst estimates for quarterly …
(RTTNews) - German insurance firm Talanx AG (TLLXY, TNXXF, TLX.DE) reported Friday higher profit in its first half of fiscal 2026 with slightly higher insurance revenue. Looking ahead for fiscal 2026, the company now expects to significantly exceed previous Group net income forecast of …
Sharemaestro market context Trend signal active 52 weeks +1.6% · Next-week setup positive 58.9%Morgan Stanley and Morgan Stanley Capital Services LLC have filed an amended Schedule 13G, disclosing their beneficial ownership in Pulmonx Corp (LUNG). Morgan Stanley reports a 6.9% stake, representing 2,920,241 shares, while Morgan Stanley Capital Services LLC reports a 6.8% stake, or 2,885,147 shares. …
Wellington Management Group LLP and its related entities have disclosed a beneficial ownership of 2.66% in NXP Semiconductors N.V., amounting to 6,719,522 shares. These shares are held for clients of various Wellington investment advisers, with shared voting power over 6,141,548 shares and shared dispositive …
Crane NXT reported stronger Q2 2026 results with increased sales and net income, alongside reaffirmed full-year sales growth guidance and a maintained quarterly dividend. While these results support the company's near-term strategy, the first half of 2026 saw slightly lower net income, suggesting recent …
Crane NXT reaffirmed its financial guidance for the fiscal year ending December 31, 2026, during the Oppenheimer 29th Annual Technology, Internet & Communications Conference. This update ensures investors that the company's expectations remain consistent with its previous second-quarter earnings release. TipRanks' AI Analyst, Spark, …
This article provides a stock forecast for CNX Resources Corporation (CNX), an independent low carbon intensity natural gas and midstream company. Argus has released a report on CNX, and the company's current price is $35.37. The report suggests an upgrade for premium users to …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations - Matt RoachePresident and Chief Executive Officer - Aaron W. SaakSenior Vice President and Chief Financial Officer - Christina Cristiano TAKEAWAYS Net Sales -- …
Search by ticker symbol or company name and select a result to open its chart.